Gleevec response in GIST varies by mutational profile, with KIT-exon-11 mutation linked to better outcomes, emphasizing ...

Hoth Therapeutics announces positive preclinical results for HT-KIT in aggressive cancer gastrointestinal stromal tumours: New York Wednesday, March 19, 2025, 18:00 Hrs [IST] Hoth ...

Hoth Therapeutics (HOTH) announced breakthrough preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted ...

The study demonstrated a considerable reduction in tumor growth and KIT protein expression, which is often associated with GIST progression. The preclinical data showed that HT-KIT could induce ...

RECKGIST score may predict recurrence in neurofibromatosis type 1 GISTs, potentially guiding treatment decisions, according ...

GSK completes acquisition of Boston-based, clinical-stage biopharma company, IDRx, Inc.

An EV powering your whole home, or even pushing power back to the grid, is something higher-end EVs might do at some point ...

Apollo Health, a leading provider of clinically proven innovative health solutions for cognition, has partnered with Trifecta Nutrition, the nation's largest science-backed meal delivery service ...

Ovation Mental Health, a wholly owned subsidiary of 3LS Ventures, is proud to announce a partnership with the Tennessee School of Beauty to provide critical mental health services for both students ...

Hoth Therapeutics Inc. has released preclinical findings demonstrating the efficacy of HT-KIT, a novel targeted therapy for gastrointestinal stromal tumors (GIST).

Fintel reports that on March 7, 2025, Scotiabank initiated coverage of Cogent Biosciences (NasdaqGS:COGT) with a Sector ...